nodes	percent_of_prediction	percent_of_DWPC	metapath
Ioflupane I 123—Neoplasm malignant—Isotretinoin—peripheral nervous system neoplasm	0.041	0.041	CcSEcCtD
Ioflupane I 123—Neoplasm malignant—Tretinoin—peripheral nervous system neoplasm	0.041	0.041	CcSEcCtD
Ioflupane I 123—Neoplasm malignant—Melphalan—peripheral nervous system neoplasm	0.0405	0.0405	CcSEcCtD
Ioflupane I 123—Neoplasm malignant—Alitretinoin—peripheral nervous system neoplasm	0.0311	0.0311	CcSEcCtD
Ioflupane I 123—Immune system disorder—Topotecan—peripheral nervous system neoplasm	0.016	0.016	CcSEcCtD
Ioflupane I 123—Immune system disorder—Melphalan—peripheral nervous system neoplasm	0.0157	0.0157	CcSEcCtD
Ioflupane I 123—Malnutrition—Topotecan—peripheral nervous system neoplasm	0.0154	0.0154	CcSEcCtD
Ioflupane I 123—Malnutrition—Tretinoin—peripheral nervous system neoplasm	0.0153	0.0153	CcSEcCtD
Ioflupane I 123—Malnutrition—Isotretinoin—peripheral nervous system neoplasm	0.0153	0.0153	CcSEcCtD
Ioflupane I 123—Injection site pain—Epirubicin—peripheral nervous system neoplasm	0.0142	0.0142	CcSEcCtD
Ioflupane I 123—Neoplasm malignant—Epirubicin—peripheral nervous system neoplasm	0.0136	0.0136	CcSEcCtD
Ioflupane I 123—Injection site pain—Doxorubicin—peripheral nervous system neoplasm	0.0132	0.0132	CcSEcCtD
Ioflupane I 123—Dry mouth—Tretinoin—peripheral nervous system neoplasm	0.0127	0.0127	CcSEcCtD
Ioflupane I 123—Dry mouth—Isotretinoin—peripheral nervous system neoplasm	0.0127	0.0127	CcSEcCtD
Ioflupane I 123—Neoplasm malignant—Doxorubicin—peripheral nervous system neoplasm	0.0126	0.0126	CcSEcCtD
Ioflupane I 123—Nervous system disorder—Topotecan—peripheral nervous system neoplasm	0.0123	0.0123	CcSEcCtD
Ioflupane I 123—Nervous system disorder—Tretinoin—peripheral nervous system neoplasm	0.0123	0.0123	CcSEcCtD
Ioflupane I 123—Nervous system disorder—Isotretinoin—peripheral nervous system neoplasm	0.0123	0.0123	CcSEcCtD
Ioflupane I 123—Malnutrition—Alitretinoin—peripheral nervous system neoplasm	0.0116	0.0116	CcSEcCtD
Ioflupane I 123—Paraesthesia—Topotecan—peripheral nervous system neoplasm	0.0113	0.0113	CcSEcCtD
Ioflupane I 123—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.0112	0.0112	CcSEcCtD
Ioflupane I 123—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.0112	0.0112	CcSEcCtD
Ioflupane I 123—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.0111	0.0111	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.0109	0.0109	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.0108	0.0108	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.0108	0.0108	CcSEcCtD
Ioflupane I 123—Pain—Topotecan—peripheral nervous system neoplasm	0.0108	0.0108	CcSEcCtD
Ioflupane I 123—Pain—Tretinoin—peripheral nervous system neoplasm	0.0107	0.0107	CcSEcCtD
Ioflupane I 123—Pain—Isotretinoin—peripheral nervous system neoplasm	0.0107	0.0107	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.0106	0.0106	CcSEcCtD
Ioflupane I 123—Pain—Melphalan—peripheral nervous system neoplasm	0.0105	0.0105	CcSEcCtD
Ioflupane I 123—Immune system disorder—Cisplatin—peripheral nervous system neoplasm	0.0103	0.0103	CcSEcCtD
Ioflupane I 123—Vertigo—Vincristine—peripheral nervous system neoplasm	0.01	0.01	CcSEcCtD
Ioflupane I 123—Malnutrition—Cisplatin—peripheral nervous system neoplasm	0.00988	0.00988	CcSEcCtD
Ioflupane I 123—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.00966	0.00966	CcSEcCtD
Ioflupane I 123—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.0094	0.0094	CcSEcCtD
Ioflupane I 123—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.00928	0.00928	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00928	0.00928	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.0092	0.0092	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.0092	0.0092	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00908	0.00908	CcSEcCtD
Ioflupane I 123—Increased appetite—Epirubicin—peripheral nervous system neoplasm	0.00897	0.00897	CcSEcCtD
Ioflupane I 123—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.00895	0.00895	CcSEcCtD
Ioflupane I 123—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.00887	0.00887	CcSEcCtD
Ioflupane I 123—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00873	0.00873	CcSEcCtD
Ioflupane I 123—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.0085	0.0085	CcSEcCtD
Ioflupane I 123—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00833	0.00833	CcSEcCtD
Ioflupane I 123—Increased appetite—Doxorubicin—peripheral nervous system neoplasm	0.0083	0.0083	CcSEcCtD
Ioflupane I 123—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00826	0.00826	CcSEcCtD
Ioflupane I 123—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00826	0.00826	CcSEcCtD
Ioflupane I 123—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.00819	0.00819	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00817	0.00817	CcSEcCtD
Ioflupane I 123—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00814	0.00814	CcSEcCtD
Ioflupane I 123—Pain—Alitretinoin—peripheral nervous system neoplasm	0.0081	0.0081	CcSEcCtD
Ioflupane I 123—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.00791	0.00791	CcSEcCtD
Ioflupane I 123—Headache—Topotecan—peripheral nervous system neoplasm	0.00789	0.00789	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00788	0.00788	CcSEcCtD
Ioflupane I 123—Headache—Tretinoin—peripheral nervous system neoplasm	0.00783	0.00783	CcSEcCtD
Ioflupane I 123—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00783	0.00783	CcSEcCtD
Ioflupane I 123—Pain—Vincristine—peripheral nervous system neoplasm	0.0078	0.0078	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00752	0.00752	CcSEcCtD
Ioflupane I 123—Nausea—Topotecan—peripheral nervous system neoplasm	0.00748	0.00748	CcSEcCtD
Ioflupane I 123—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00742	0.00742	CcSEcCtD
Ioflupane I 123—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00742	0.00742	CcSEcCtD
Ioflupane I 123—Nausea—Melphalan—peripheral nervous system neoplasm	0.00732	0.00732	CcSEcCtD
Ioflupane I 123—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00724	0.00724	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00698	0.00698	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00696	0.00696	CcSEcCtD
Ioflupane I 123—Pain—Cisplatin—peripheral nervous system neoplasm	0.0069	0.0069	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00672	0.00672	CcSEcCtD
Ioflupane I 123—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00664	0.00664	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.00638	0.00638	CcSEcCtD
Ioflupane I 123—Pain—Etoposide—peripheral nervous system neoplasm	0.00632	0.00632	CcSEcCtD
Ioflupane I 123—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00626	0.00626	CcSEcCtD
Ioflupane I 123—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00607	0.00607	CcSEcCtD
Ioflupane I 123—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00603	0.00603	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00594	0.00594	CcSEcCtD
Ioflupane I 123—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00593	0.00593	CcSEcCtD
Ioflupane I 123—Headache—Vincristine—peripheral nervous system neoplasm	0.00572	0.00572	CcSEcCtD
Ioflupane I 123—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00562	0.00562	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00544	0.00544	CcSEcCtD
Ioflupane I 123—Nausea—Vincristine—peripheral nervous system neoplasm	0.00542	0.00542	CcSEcCtD
Ioflupane I 123—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.00527	0.00527	CcSEcCtD
Ioflupane I 123—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.00508	0.00508	CcSEcCtD
Ioflupane I 123—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.00497	0.00497	CcSEcCtD
Ioflupane I 123—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00489	0.00489	CcSEcCtD
Ioflupane I 123—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00487	0.00487	CcSEcCtD
Ioflupane I 123—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00479	0.00479	CcSEcCtD
Ioflupane I 123—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.0047	0.0047	CcSEcCtD
Ioflupane I 123—Headache—Etoposide—peripheral nervous system neoplasm	0.00463	0.00463	CcSEcCtD
Ioflupane I 123—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.0046	0.0046	CcSEcCtD
Ioflupane I 123—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.00456	0.00456	CcSEcCtD
Ioflupane I 123—Nausea—Etoposide—peripheral nervous system neoplasm	0.00439	0.00439	CcSEcCtD
Ioflupane I 123—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.00423	0.00423	CcSEcCtD
Ioflupane I 123—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.00422	0.00422	CcSEcCtD
Ioflupane I 123—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.00406	0.00406	CcSEcCtD
Ioflupane I 123—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.00391	0.00391	CcSEcCtD
Ioflupane I 123—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00376	0.00376	CcSEcCtD
Ioflupane I 123—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.00372	0.00372	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.00358	0.00358	CcSEcCtD
Ioflupane I 123—Pain—Epirubicin—peripheral nervous system neoplasm	0.00354	0.00354	CcSEcCtD
Ioflupane I 123—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.00344	0.00344	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.00331	0.00331	CcSEcCtD
Ioflupane I 123—Pain—Doxorubicin—peripheral nervous system neoplasm	0.00328	0.00328	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.00305	0.00305	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00282	0.00282	CcSEcCtD
Ioflupane I 123—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.00274	0.00274	CcSEcCtD
Ioflupane I 123—Headache—Epirubicin—peripheral nervous system neoplasm	0.0026	0.0026	CcSEcCtD
Ioflupane I 123—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.00253	0.00253	CcSEcCtD
Ioflupane I 123—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00246	0.00246	CcSEcCtD
Ioflupane I 123—Headache—Doxorubicin—peripheral nervous system neoplasm	0.0024	0.0024	CcSEcCtD
Ioflupane I 123—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00228	0.00228	CcSEcCtD
